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Abstract
Objectives—Bayesian meta-analysis is a frequently cited but very little-used method for
synthesizing qualitative and quantitative research findings. The only example published to date used
qualitative data to generate an informative prior probability and quantitative data to generate the
likelihood. We developed a method to incorporate both qualitative and quantitative evidence in the
likelihood in a Bayesian synthesis of evidence about the relationship between regimen complexity
and medication adherence.
Methods—Data were from 11 qualitative and six quantitative studies. We updated two different
non-informative prior distributions with qualitative and quantitative findings to find the posterior
distribution for the probabilities that a more complex regimen was associated with lower adherence
and that a less complex regimen was associated with greater adherence.
Results—The posterior mode for the qualitative findings regarding more complex regimen and
lesser adherence (using the uniform prior with Jeffreys' prior yielding highly similar estimates) was
0.588 (95% credible set limits 0.519, 0.663) and for the quantitative findings was 0.224 (0.203,
0.245); due to non-overlapping credible sets, we did not combine them. The posterior mode for the
qualitative findings regarding less complex regimen and greater adherence was 0.288 (0.214, 0.441)
and for the quantitative findings was 0.272 (0.118, 0.437); the combined estimate was 0.299 (0.267,
0.334).
Conclusions—The utility of Bayesian methods for synthesizing qualitative and quantitative
research findings at the participant level may depend on the nature of the relationship being
synthesized and on how well the findings are represented in the individual reports.
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Among the most frequently cited but as yet very little-used methods for synthesizing qualitative
and quantitative research findings is Bayesian meta-analysis.1-3 A Bayesian analysis begins
with a prior distribution describing plausible potential values for parameters that will be
estimated. This distribution may be informative, taking account of previous data or expert
beliefs, or it may be non-informative, allowing equitably for any of a wide range of parameter
values to be true. The distribution of the observed data is then described by writing the
likelihood as a function of parameter values. In the final step, the prior distribution and
likelihood distribution are multiplied and normalized to create a posterior distribution for each
parameter. The mean, median or mode of the posterior distribution can be taken as the point
estimate of the parameter, and credible set limits (a Bayesian analog to a confidence interval)
can be calculated to describe the uncertainty in the estimate.
The only paper referred to as an example of Bayesian meta-analysis of both qualitative and
quantitative evidence and, to our knowledge, the only paper to date showing the use and results
of this synthesis method is a report by Roberts and colleagues4 of a study of factors affecting
the uptake of childhood immunizations.
A quick perusal of CINAHL (Cumulative Index of Nursing and Allied Health Literature),
Google Scholar, Thompson ISI Web of Science, Psyclnfo, PubMed and ScienceDirect shows
that of the 44 unique references to this article (as of 19 November 2008), 73% were solely to
identify it as an example of Bayesian meta-analysis and the remainder, to support an argument
concerning childhood immunization. We know of no-one other than Roberts et al. who has
used a Bayesian approach to synthesize qualitative and quantitative findings, nor anyone who
critically analysed what Roberts et al. did. In this article, we first examine the Roberts et al.
paper, then we describe the results of a Bayesian analysis we conducted of qualitative and
quantitative findings on antiretroviral adherence and how this analysis diverged from the one
Roberts et al. described.
The Roberts et al. report
The stated goal of the Roberts et al.4 study was to identify the factors that predict uptake of
childhood immunizations. To begin, the investigators listed, ranked and weighed factors they
believed affected uptake of childhood immunizations. They then reviewed 11 qualitative
studies regarding factors that affect uptake and updated their beliefs based on that evidence.
Their updated beliefs were combined to estimate the prior probability that each factor was
associated with immunization uptake. The quantitative evidence was then used to generate the
likelihood, which updated their expert beliefs to create a posterior probability.
Their analysis had two characteristics that we directly address in this article. First, the
qualitative and quantitative findings were not treated equally. The qualitative evidence was
used to refine the prior probabilities, but only the quantitative evidence was considered to
constitute the data in the Bayesian analysis, and it alone contributed to the likelihood. This is
only one possible way of using the Bayesian paradigm to synthesize qualitative and quantitative
findings. Data from both qualitative and quantitative studies could enter the analysis in the
same phase. Second, Roberts et al. were not able to construct credible intervals quantifying
the uncertainty in their probability estimates (although their approach could be expanded to
include credible intervals by assigning a distribution to the probabilities corresponding to each
factor and/or using a different estimation method, such as Markov Chain Monte Carlo). The
estimate of the probability of an effect is more meaningful when a measure of the variability
of the estimate is provided.
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Our goal was to apply a Bayesian method for synthesis of qualitative and quantitative findings
that allowed the qualitative and quantitative evidence to affect the results in the same way, and
that produced a measure of uncertainty in the estimate of the probability of an effect. Due to
the complexity of the method, we synthesized the findings on only the effect of one factor and
its converse for illustrative purposes. We show how we applied Bayesian methods to synthesize
a set of qualitative and quantitative research findings on the relationship between regimen
complexity and adherence to antiretroviral medications in HIV-positive women.
Methods
Data for the synthesis
The data for the analysis consisted of qualitative and quantitative reports of empirical studies
of antiretroviral adherence in HIV-positive women of any race/ethnicity, class or nationality
living in the USA. These reports are part of a larger collection retrieved in the course of a study
aimed at developing methods for synthesizing qualitative and quantitative research findings.
They were retrieved between June 2005 and January 2006, with updates in June 2006 and
October 2007, using 40 databases housing citations to literature across the health, behavioral
and social sciences. Reports were eligible for inclusion if they were of qualitative and
quantitative observational studies of adherence to antiretroviral therapy conducted with HIV-
positive women and published in or after 1997 (when protease inhibitors became part of the
standard of care) to 2007. The research question asked of this set of reports was: ‘Which factors
are (positively or negatively) associated with medication adherence?’
For the purposes of clearly demonstrating our application of Bayesian methods for combining
qualitative and quantitative findings, we focused on a set of findings pertaining to a relationship
addressed in both qualitative and quantitative studies, namely, the association between
adherence and regimen complexity. This relationship was the most frequently addressed in
both types of reports: 11 qualitative and 10 quantitative reports. Common to all of these studies
was the reduction of the interview or focus group data collected in ways that remained close
to those data as given to the researcher, that is, with minimal interpretation or transformation,
or what Sandelowski and Barroso referred to as qualitative survey findings.5 The quantitative
studies reviewed included observational studies of factors associated with adherence.
Regimen complexity is a broad category of factors commonly appearing in systematic reviews
of research on antiretroviral adherence and consisting of an array of diverse factors. In
systematic reviews, it is usually necessary to combine factors seen to be similar and, therefore,
treatable as the same because otherwise, there would be few findings available to synthesize,
no matter what the method of synthesis used. We included in the medication regimen category
any finding addressing dosing frequency, size of pills, timing of medications, availability of
medication refills, medication side-effects, ease or difficulty of incorporation of pill-taking
into daily routine, dietary requirements of drugs and regimen changes.
Determining the prior and posterior distributions
Our first step was to determine what would constitute the prior distribution. Prior distributions
can be broadly classified into two types: informative and non-informative. Informative prior
distributions are derived from a source, such as previous data or expert opinion. Roberts et al.
4 used the qualitative findings, combined with their own expert opinions, to generate a prior
probability. In contrast, we wanted to treat the qualitative research findings as evidence
contributing to the posterior probability, which is more in keeping with the calls to give
qualitative findings equal weight with quantitative findings in evidence-based syntheses. We
could have sought expert opinion to help create an informative prior distribution, but to allow
for the posterior distributions to be dominated by the likelihoods of the qualitative and
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quantitative evidence, we used non-informative prior distributions. Such distributions have no
population basis and, as such, have a minimal effect on the posterior distribution, which is
informed primarily by the observed data used to construct the likelihood. There are different
possibilities for prior distributions. For example, the uniform prior is a perfectly non-
informative prior, giving every possible outcome the exact same prior probability. Frequently,
the uniform prior is undesirable, so Jeffreys' prior6 is used because its mathematical properties
make it fairly non-informative.7 As explained further below, we conducted the analyses both
ways – using the uniform and Jeffreys' prior distributions – to ensure that our choice had no
measurable effect on the posterior point estimate.
Deciding how to synthesize the findings
Before the qualitative and quantitative findings were to be combined to update the prior and
generate the posterior distribution, we had to find a common metric. This proved challenging,
as qualitative findings are usually represented at the study level, with thematic and interpretive
lines typically prevailing over frequency counts, and within-participant or between-thematic
lines comparisons typically prevailing over between- and cross-participant comparisons. Partly
a consequence of open-ended and minimally structured modes of data collection resulting in
non-comparable data-sets, in reports of qualitative studies, no one may have mentioned an
association (which could be coded as 0), or ≥1 participants may have mentioned the association
(which could be coded as 1). In contrast, quantitative findings are represented as group-level
statistics (e.g. odds ratio) based on participant-level information.
Given these differences, we broadly defined two options for finding a common metric
whenever the qualitative and quantitative findings will be used to calculate the likelihood. One
option is to make the quantitative findings more like the qualitative findings by summarizing
them at the study level. Thus, we would be estimating the probability that a study was linked
to a finding. One way to do this might be to assign a value of 0 or 1 to each study to indicate
whether the finding was absent or present, respectively. This could be accomplished by using
a predetermined p value or odds ratio as a threshold. Thus, for example, if the odds ratio in a
study were greater than the predetermined threshold, the study would receive a value of 1;
otherwise, it would receive a 0. The findings could then be combined with the study-level
qualitative findings. This solution is limited because it does not reflect the proportion of
participants for whom, for example, a more complex regimen was associated with lesser
adherence, thus resulting in a loss of information.
The alternative option is to make the qualitative findings more like the quantitative findings
by summarizing them at the participant level. Thus, we would be estimating the probability
that a participant was linked to a finding. This could be accomplished by extracting from the
qualitative reports all information pertaining to the frequency of a finding and sample size and
then using that information to estimate the proportion of participants for whom the finding was
true. The corresponding proportion could then be calculated for the quantitative studies.
From an initial reading of the qualitative and quantitative reports, we found that there were
two possible associations to summarize: more complex regimen associated with lesser
adherence, or less complex regimen associated with greater adherence. In the quantitative
reports, these two categories were mutually exclusive (i.e. statistically independent) because
each participant was categorized as more adherent or less adherent in relation to a more complex
regimen or a less complex regimen. In contrast, in the qualitative reports, participants fell into
one, both, or neither category. For example, a woman reporting that she did not adhere because
the regimen was too complex could not be assumed to be adherent with a less complex regimen.
A woman who reported decreased adherence after a switch to a more complex regimen would
fit into both categories.
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If the categories had been statistically independent (i.e. represented by different participants)
for both the qualitative and quantitative data, then we could have analysed them together.
Because of the nature of the qualitative data in the studies reviewed, however, we could only
synthesize findings concerning one component of the association between regimen complexity
and adherence at a time because otherwise we would be counting some participants twice.
Thus, we synthesized separately the association between a more complex regimen and lesser
adherence, and the association between a less complex regimen and greater adherence.
Calculating the proportion of participants associated with a finding
Qualitative findings—While reviewing the qualitative reports, it became apparent to us that
determining the number of participants indicating that a more complex regimen was associated
with lesser adherence or that a less complex regimen was associated with greater adherence
would be difficult, as the findings in these reports were typically presented with verbal count
adjectives such as ‘few’, ‘many’ and ‘most’. As described more fully elsewhere,8 this is not a
deficiency of qualitative research per se, but rather a reflection of the differences between the
purposeful sampling and analytic imperatives associated with qualitative research and the
probability sampling and analytic imperatives associated with quantitative research. Moreover,
this style of reporting findings is characteristic of qualitative survey research, which
characterizes the qualitative studies in our data-set. Because qualitative survey findings are
similar in form and interpretive level to quantitative findings, they are more amenable to
quantitative transformation than highly interpretive qualitative findings.9 We, therefore,
developed a method to transform these verbal counts into numbers. The details of this method
are fully described elsewhere.8 Briefly, we used the results of a quantitative survey we
conducted to ascertain which specific numbers, or ranges of numbers, respondents had in mind
when using seven verbal count terms (couple, few, majority, many, most, several and some)
for each of four sample sizes common in qualitative studies: 5, 10, 20 and 50. For each sample
size, we constructed a range for each of the seven words using the smallest and largest number
reported. To avoid the influence of outliers on these ranges, if the smallest or largest number
for a word was reported by only one respondent, we discarded that number and used the second-
smallest or the second-largest reported value. To apply the results of the survey to the actual
sample sizes in the 11 qualitative reports, we estimated the mathematical relationship between
sample size and the number represented by each word by fitting a regression equation for the
lower and upper limit of the range for each of the seven words. Table 1 shows the results of
this method for both findings for each of the 11 qualitative reports.
Quantitative findings—To calculate the proportion of participants associated with each
finding in the quantitative reports, we extracted all bivariate (unadjusted) findings, as it is
impossible to calculate the percentage of people reporting a finding from multivariable
(adjusted) results. We excluded two reports for which the outcome was mean adherence, as
there was no way to calculate percentages, and two other reports that did not provide sufficient
information for calculating percentages, even after contacting the authors. As a result of these
exclusions, we were able to calculate percentages for 6 of the 10 quantitative reports (Table
2). Some of these reports contain findings from more than one variable that could be classified
as medication regimen. To meet the independence assumption (i.e. participants may contribute
to only one finding) for any quantitative synthesis method, we extracted the variable from each
report that was most similar to the variables from other reports. In five of the six reports that
we utilized, that variable was regimen type (HAART versus pre-HAART, or combination
therapy versus monotherapy); in the remaining study, the variable was having too many pills
to take.
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We applied Bayesian methods to determine the probabilities of a participant reporting that a
more complex medication regimen was associated with lesser adherence and of a participant
reporting that a less complex regimen was associated with greater adherence. The following
methods were used to calculate each probability separately. First, for each finding, we
synthesized the qualitative and quantitative findings individually. As they are typically
classified as different methods, all of the qualitative studies could be seen as estimating one
probability, and all of the quantitative studies could be seen as estimating another probability.
We do not mean to invoke stereotypes of qualitative and quantitative research, as the dichotomy
is often false. Rather, we argue that researchers should examine each set of studies critically
to determine whether and how the two types of studies differ. If both types of studies estimate
the same probability, the posterior distributions will be similar and we can combine them to
estimate the posterior probability. If the posterior distributions are very different (as indicated
by nonoverlapping 95% credible sets), this may be an indication that the two study types are
not estimating the same probability and, arguably, that the distributions should not be
combined.
We analysed the data using two different prior distributions: (1) the uniform prior, allowing
all probabilities of an effect to be equally likely; and (2) the standard Jeffreys' prior6 (Figure
1). We wrote the likelihood for each study using the observed data, then combined the prior
distribution and the likelihood to form a posterior distribution. The likelihoods were combined
by multiplying them together using the Mathematica software.10
Each quantitative study can be thought of as a draw from a binomial distribution, where the
possible number of ‘successes’ (i.e. times the effect is observed) is equal to the total sample
size. The probability that a participant is linked to the finding is represented by probability p.
To test whether the quantitative studies all had the same underlying value of p, we calculated
an index of heterogeneity. For the association between more complex regimen and lesser
adherence, Cochrane's Q was χ2 (5, n = 6) = 17.846, p = 0.003, and for the association between
less complex regimen and greater adherence, it was χ2 (5, n = 6) = 138.36, p < 0.001. This
suggests the presence of heterogeneity and that a fixed effects model (i.e. a single value of p)
is inappropriate. Therefore, we used the beta-binomial random effects model.11
In this model, the parameter, p, is randomly varying across studies according to a beta
distribution with parameters α,β. The resulting distribution is no longer called a binomial
distribution, but rather a beta-binomial distribution:
where B(α, β) is the beta function.12 Equivalently, the distribution can be written as:
where .
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The parameter estimates were calculated using the modified Gauss-Newton method.13 The
posterior mean and 95% credible set limits were computed using the FAST*PRO Software.14
Results
Association between a more complex medication regimen and lesser adherence
The resulting posterior probability for the qualitative studies is shown on the right side of Figure
2 (in all cases, the same shape results, regardless of which prior was used). Using the uniform
prior, the posterior mode for the probability of adherence in the qualitative studies was 0.588
(95% credible set limits 0.519, 0.663). Using Jeffreys' prior changed the estimate very slightly,
with a posterior mode of 0.589 (0.519, 0.664). Further examination of the results revealed that
the following studies had a minimal effect on the posterior mode (i.e. the credible set limits
and posterior mode remain the same to 3 decimal places): Misener and Sowell,15 Remien et
al.,16 Richter et al.,17 Siegel and Gorey,18 Siegel et al.19 and Wood et al.20 This is because the
estimated ranges were wide relative to the study n, leading to a large amount of imprecision.
The resulting posterior probability for the quantitative studies is shown on the left side of Figure
2. Using the uniform prior, the posterior mode for the probability of adherence in the
quantitative studies was 0.224 (0.203, 0.245). Using Jeffreys' prior, the posterior mode was
0.222 (0.182, 0.268).
Because the point estimates for the qualitative and quantitative studies were vastly different,
with non-overlapping credible sets, it is possible that each set of findings is estimating a
different probability. Therefore, we did not combine them into a single point estimate, and no
statistically meaningful conclusion could be drawn about the relationship between a more
complex regimen and lesser adherence.
Association between a less complex medication regimen and greater adherence
The resulting posterior probability for the qualitative studies is shown in Figure 3. Using the
uniform prior, the posterior mode for the probability of adherence in the qualitative studies
was 0.288 (0.214, 0.441). Using Jeffreys' prior changed the estimate very slightly, with a
posterior mode of 0.272 (0.118, 0.437). Using the uniform prior, the posterior mode for the
probability of adherence in the quantitative studies was 0.297 (0.258, 0.339). Using Jeffreys'
prior, the posterior mode was 0.299 (0.260, 0.341).
Because the point estimates for the qualitative and quantitative studies were very similar, with
overlapping credible sets, we combined them into a single point estimate. Using the uniform
prior, the posterior mode was 0.300 (0.267, 0.334). Using Jeffreys' prior, the posterior mode
was 0.299 (0.267, 0.334). As shown in Figure 3, in this example, the combined posterior is
more similar to the posterior from the quantitative studies. This is because the posterior from
the qualitative studies is relatively flat over the region where the posterior from the qualitative
studies has appreciable mass.
Discussion
To our knowledge, Roberts and colleagues4 were the first to demonstrate the use of Bayesian
methods to synthesize qualitative and quantitative research findings. Our approach differed
from theirs in a few key ways. For one, Roberts et al. used the qualitative research findings to
inform the prior probability, which was then updated with quantitative evidence to create a
posterior probability. In contrast, we used two different non-informative prior distributions,
with the goal of updating them with the qualitative and quantitative research findings. Our
approach also differed from Roberts et al. in that we calculated 95% credible set limits to
indicate the degree of certainty about the point estimates (although this could be added easily
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to their approach). Finally, we synthesized findings of two relationships to determine if this
affected our ability to synthesize findings or the estimated posterior probabilities.
Our conclusions differed according to which relationship was synthesized. When synthesizing
the relationship between a more complex regimen and lesser adherence, the qualitative data
yielded a much greater estimate of the probability than did the quantitative data, and the two
estimates had non-overlapping 95% credible sets. Moreover, the distribution for the
quantitative findings was narrower and more precise (i.e. less variability) than the distribution
for the qualitative findings, likely owing to the use of ranges rather than precise probability
estimates. Although combining the two distributions into a mixture distribution is
mathematically possible, the resulting estimate may not be meaningful because the studies
were drawn from two different, known populations of studies (i.e. qualitative and quantitative).
The probabilities should only be combined if they were assumed to be drawn from a single
population of studies.
In contrast, when synthesizing the relationship between a less complex regimen and greater
adherence, the posterior modes were very similar, with overlapping credible sets; therefore,
we were able to combine the estimates into an overall probability estimate. As before, wider
95% credible sets were obtained for the qualitative, in comparison to the quantitative, estimates.
Another way of viewing these findings is that the posterior modes for the two complementary
quantitative relationships were similar, whereas for the qualitative relationships, they were
quite different. Inspection of columns 3 and 4 of Table 1 indicates that the derived ranges were
wider, and, in some cases, unknown (thus not contributing to the synthesis), for the relationship
between less complex regimen and greater adherence than for the relationship between more
complex regimen and lesser adherence. This is sensible because in many studies, participants
were asked what made it difficult to adhere to the regimen, as opposed to what made it easy
or a non-valence question about adherence in general. Even subtle differences in the way
questions are worded, to obtain information about ostensibly the same phenomenon, has long
been understood to have a profound impact on responses.21 Moreover, it cannot be assumed
that asking an individual what makes it hard to adhere yields information about what makes it
easy; they are not symmetrically opposite questions.22
One limitation of our approach is that the posterior probability estimates for the qualitative
studies may be inaccurate due to the method we used to calculate the range estimates. Due to
the way that the qualitative findings were reported, we did not have information on the number
of participants for each finding, which led us to the effort to calculate ranges. Although
obtaining estimates is not the goal of qualitative research, in order to synthesize qualitative and
quantitative research findings mathematically, this information will sometimes be needed. Our
calculations were contingent on authors choosing words that have shared meaning. For
example, if the authors reported that ‘many’ participants reported a finding to denote that 20–
30% did, but ‘many’ is commonly understood as >50%, as we found previously,8 then the
ranges and, thus, the probabilities that we calculated will be inflated. Although the ranges
provided us with more precision than would have been available otherwise (i.e. the only
information provided was that the finding was true for 1 to n), they were still relatively large.
This contributed to wider credible intervals for the qualitative findings. This method for
estimating ranges and calculating probabilities is only possible when the qualitative data are
presented as qualitative survey findings, which are largely untransformed and remain close to
data as given. More interpretive qualitative findings (e.g. in the form of grounded theories or
ethnographic explanations) would not lend themselves to the synthesis method presented here
because their goal is not to generate lists of ideas or occurrences that are, in turn, more amenable
to counting.
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Another limitation is that the regimen complexity category was defined differently in
qualitative and quantitative studies. We chose regimen complexity because it was available in
(some of) both types of reports. Within this category, we were only able to synthesize some of
the quantitative findings because of differences in measurement (continuous vs. dichotomous
outcome) and because some reports contained insufficient information for calculating
proportions. Nonetheless, in five of the six quantitative reports, the same variable was used
and thus synthesized (HAART vs. non-HAART regimen). In contrast, in the qualitative reports,
several different aspects of regimen complexity were mentioned, even within a single study.
For example, in a case in which the minimum n was 2, one person may have mentioned pill
size whereas the second person may have mentioned availability of medication refills.
Moreover, the most frequently mentioned aspect of regimen complexity in the qualitative
reports was side-effects. Thus, the components of regimen complexity were different for the
qualitative and quantitative studies. This limitation will be difficult to circumvent when
conducting a synthesis of qualitative and quantitative findings. As mentioned previously,
combining factors that can be seen as similar is usually necessary in any effort to synthesize
findings, otherwise there would be too few findings to synthesize. If we were only willing to
combine factors that were defined and operationalized the same way across studies, we would
not have been able to combine any association.
Although Bayesian methods have been promoted for synthesizing qualitative and quantitative
research findings, they may have limited utility.3 At issue is whether both types of research
findings can be treated as evidence, factoring into the calculation of the likelihood, and whether
the findings can be represented at the participant level and/or the study level. Our attempt to
synthesize the relationship between regimen complexity and adherence at the participant level
revealed that the conclusion may depend on the nature of the relationship and on the ability to
obtain precise frequencies associated with each finding. Future research should investigate
whether Bayesian methods to synthesize qualitative and quantitative research findings at the
study level (i.e. finding present or absent in each study) prove more fruitful because this
information is readily available in both types of reports. Indeed, we have taken this approach
in a different analysis, but because of the amount of detail required to describe it, we will report
our results elsewhere.
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Prior distribution of the probability of a participant reporting a relationship
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Posterior distribution of the probability of a participant reporting the relationship between a
more complex regimen and lesser adherence
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Posterior distribution of the probability of a participant reporting the relationship between a
less complex regimen and greater adherence
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Table 1
Findings from 11 qualitative reports on the relationship between a more complex medication regimen and lesser














Abel & Painter, 200323 6 2–6 1–6
Gant and Welch, 200424 30 3–15 2–12
Misener and Sowell, 199815 22 6–22 3–11
Powell-Cope et al., 200325 24 13–24 1–24
Remien et al., 200316 110 56–110 5–103
Richter et al., 200217 33 2–33 2–13
Roberts and Mann, 200026 20 15–20 NF
Schrimshaw et al., 200527 158 100–142 16–79
Siegel and Gorey, 199718 71 15–71 NF
Siegel et al., 200119 51 11–51 NF
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Table 2
Findings from six quantitative reports on the relationship between a more complex medication regimen and lesser
adherence and between a less complex medication regimen and greater adherence
Report Total (n) Non-adherence (n)a Adherence (n)b
Durante et al.28 48 12 12
Phillips et al.29 125 21 8
Schuman et al.30 326 57 18
Stone et al.31 186 59 71
Wilson et al.32 562 136 159
Wilson et al.33 132 25 74
a
Number of women for whom a more complex regimen was associated with less adherence
b
Number of women for whom a less complex regimen was associated with more adherence
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